ImmunoGen, Inc. (IMGN)

NASDAQ: IMGN · IEX Real-Time Price · USD
5.31
+0.04 (0.76%)
At close: Aug 10, 2022 4:00 PM
5.16
-0.15 (-2.82%)
After-hours: Aug 10, 2022 5:48 PM EDT

Stock Price Forecast

According to 16 stock analysts, the average 12-month stock price forecast for ImmunoGen stock is $12.09, which predicts an increase of 127.68%. The lowest target is $4.04 and the highest is $21. On average, analysts rate ImmunoGen stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $4.04 $12.09 $12.24 $21
Change -23.92% +127.68% +130.51% +295.48%

Analyst Ratings

The average analyst rating for ImmunoGen stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Feb '22Mar '22Apr '22May '22Jun '22Jul '22
Strong Buy 666666
Buy 676666
Hold 445444
Sell 000000
Strong Sell 000000
Total 161717161616

Financial Forecast

Revenue This Year
87.44M
Increased by 25.17%
Revenue Next Year
138.97M
Increased by 58.93%
EPS This Year
-0.84
EPS Next Year
-0.76
Year 2017201820192020202120222023202420252026
Revenue
115.45M53.45M82.27M132.30M69.86M87.44M138.97M314.61M594.22M1.14B
Revenue Growth
92.41%
-53.71%
53.93%
60.81%
-47.20%
25.17%
58.93%
126.38%
88.88%
92.66%
EPS
-0.98-1.21-0.70-0.25-0.68-0.84-0.76-0.17-0.23-0.34
EPS Growth
----------
No. Analysts -----12121066

Revenue Forecast

Revenue 20222023202420252026
High 118.7M 259.2M 565.6M 623.9M 1.2B
Avg 87.4M 139.0M 314.6M 594.2M 1.1B
Low 74.1M 68.0M 162.6M 576.4M 1.1B

Revenue Growth

Revenue Growth 20222023202420252026
High
70.0%
196.4%
307.0%
98.3%
100.4%
Avg
25.3%
58.9%
126.4%
88.9%
92.7%
Low
6.2%
-22.2%
17.0%
83.2%
86.9%

EPS Forecast

EPS 20222023202420252026
High -0.67 -0.48 0.57 -0.25 -0.35
Avg -0.84 -0.76 -0.17 -0.23 -0.34
Low -1.01 -0.89 -0.58 -0.23 -0.33

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -